NM_001122955.4:c.766-49T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001122955.4(BSCL2):​c.766-49T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.761 in 1,609,882 control chromosomes in the GnomAD database, including 467,733 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.75 ( 43324 hom., cov: 31)
Exomes 𝑓: 0.76 ( 424409 hom. )

Consequence

BSCL2
NM_001122955.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.240

Publications

12 publications found
Variant links:
Genes affected
BSCL2 (HGNC:15832): (BSCL2 lipid droplet biogenesis associated, seipin) This gene encodes the multi-pass transmembrane protein protein seipin. This protein localizes to the endoplasmic reticulum and may be important for lipid droplet morphology. Mutations in this gene have been associated with congenital generalized lipodystrophy type 2 or Berardinelli-Seip syndrome, a rare autosomal recessive disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. Naturally occurring read-through transcription occurs between this locus and the neighboring locus HNRNPUL2 (heterogeneous nuclear ribonucleoprotein U-like 2).[provided by RefSeq, Mar 2011]
HNRNPUL2-BSCL2 (HGNC:49189): (HNRNPUL2-BSCL2 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring HNRNPUL2 (heterogeneous nuclear ribonucleoprotein U-like 2) and BSCL2 (Berardinelli-Seip congenital lipodystrophy 2 (seipin)) genes on chromosome 11. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is unlikely to produce a protein product. [provided by RefSeq, Mar 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 11-62692522-A-G is Benign according to our data. Variant chr11-62692522-A-G is described in ClinVar as Benign. ClinVar VariationId is 257500.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.818 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001122955.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BSCL2
NM_001122955.4
MANE Select
c.766-49T>C
intron
N/ANP_001116427.1Q96G97-4
BSCL2
NM_001386027.1
c.766-49T>C
intron
N/ANP_001372956.1J3KQ12
BSCL2
NM_001386028.1
c.766-49T>C
intron
N/ANP_001372957.1Q96G97-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BSCL2
ENST00000360796.10
TSL:1 MANE Select
c.766-49T>C
intron
N/AENSP00000354032.5Q96G97-4
BSCL2
ENST00000405837.5
TSL:1
c.766-49T>C
intron
N/AENSP00000385332.1J3KQ12
BSCL2
ENST00000407022.7
TSL:1
c.574-49T>C
intron
N/AENSP00000384080.3Q96G97-2

Frequencies

GnomAD3 genomes
AF:
0.753
AC:
114452
AN:
151960
Hom.:
43300
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.675
Gnomad AMI
AF:
0.803
Gnomad AMR
AF:
0.830
Gnomad ASJ
AF:
0.771
Gnomad EAS
AF:
0.772
Gnomad SAS
AF:
0.787
Gnomad FIN
AF:
0.854
Gnomad MID
AF:
0.785
Gnomad NFE
AF:
0.762
Gnomad OTH
AF:
0.754
GnomAD2 exomes
AF:
0.781
AC:
192316
AN:
246176
AF XY:
0.781
show subpopulations
Gnomad AFR exome
AF:
0.672
Gnomad AMR exome
AF:
0.847
Gnomad ASJ exome
AF:
0.772
Gnomad EAS exome
AF:
0.769
Gnomad FIN exome
AF:
0.848
Gnomad NFE exome
AF:
0.761
Gnomad OTH exome
AF:
0.792
GnomAD4 exome
AF:
0.762
AC:
1111342
AN:
1457804
Hom.:
424409
Cov.:
35
AF XY:
0.764
AC XY:
553977
AN XY:
725170
show subpopulations
African (AFR)
AF:
0.663
AC:
22154
AN:
33430
American (AMR)
AF:
0.846
AC:
37593
AN:
44424
Ashkenazi Jewish (ASJ)
AF:
0.772
AC:
20165
AN:
26120
East Asian (EAS)
AF:
0.747
AC:
29635
AN:
39662
South Asian (SAS)
AF:
0.800
AC:
68940
AN:
86160
European-Finnish (FIN)
AF:
0.844
AC:
44167
AN:
52322
Middle Eastern (MID)
AF:
0.787
AC:
4516
AN:
5738
European-Non Finnish (NFE)
AF:
0.755
AC:
837648
AN:
1109698
Other (OTH)
AF:
0.772
AC:
46524
AN:
60250
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
15817
31634
47452
63269
79086
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20306
40612
60918
81224
101530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.753
AC:
114525
AN:
152078
Hom.:
43324
Cov.:
31
AF XY:
0.759
AC XY:
56390
AN XY:
74326
show subpopulations
African (AFR)
AF:
0.675
AC:
27978
AN:
41458
American (AMR)
AF:
0.830
AC:
12689
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.771
AC:
2677
AN:
3470
East Asian (EAS)
AF:
0.772
AC:
3991
AN:
5170
South Asian (SAS)
AF:
0.789
AC:
3803
AN:
4820
European-Finnish (FIN)
AF:
0.854
AC:
9039
AN:
10590
Middle Eastern (MID)
AF:
0.779
AC:
229
AN:
294
European-Non Finnish (NFE)
AF:
0.762
AC:
51797
AN:
67962
Other (OTH)
AF:
0.752
AC:
1591
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1458
2916
4374
5832
7290
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
856
1712
2568
3424
4280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.762
Hom.:
9106
Bravo
AF:
0.747
Asia WGS
AF:
0.786
AC:
2732
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Congenital generalized lipodystrophy type 2 (1)
-
-
1
Hereditary spastic paraplegia 17 (1)
-
-
1
Neuronopathy, distal hereditary motor, type 5C (1)
-
-
1
not specified (1)
-
-
1
Severe neurodegenerative syndrome with lipodystrophy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
4.5
DANN
Benign
0.38
PhyloP100
0.24
PromoterAI
-0.019
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2850597; hg19: chr11-62459994; API